PL365005A1 - Kompozycje farmaceutyczne - Google Patents

Kompozycje farmaceutyczne

Info

Publication number
PL365005A1
PL365005A1 PL01365005A PL36500501A PL365005A1 PL 365005 A1 PL365005 A1 PL 365005A1 PL 01365005 A PL01365005 A PL 01365005A PL 36500501 A PL36500501 A PL 36500501A PL 365005 A1 PL365005 A1 PL 365005A1
Authority
PL
Poland
Prior art keywords
cannabis
hfc
formulation
derivatives
synthetic
Prior art date
Application number
PL01365005A
Other languages
English (en)
Other versions
PL202673B1 (pl
Inventor
Calvin Ross
Original Assignee
Gw Pharma Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0005718A external-priority patent/GB2361869B/en
Priority claimed from GB0101743A external-priority patent/GB0101743D0/en
Priority claimed from GB0101744A external-priority patent/GB0101744D0/en
Application filed by Gw Pharma Limited filed Critical Gw Pharma Limited
Publication of PL365005A1 publication Critical patent/PL365005A1/pl
Publication of PL202673B1 publication Critical patent/PL202673B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant
    • B65D83/44—Valves specially adapted for the discharge of contents; Regulating devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Physiology (AREA)
  • Mechanical Engineering (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
PL365005A 2000-03-09 2001-03-09 Zastosowanie kanabisu, delta 9-tetrahydrokanabinolu do wytwarzania kompozycji farmaceutycznej oraz urządzenie spreju z pompą zawierające kompozycję farmaceutyczną PL202673B1 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0005718A GB2361869B (en) 2000-03-09 2000-03-09 Sublingual delivery of cannabis
GB0101743A GB0101743D0 (en) 2001-01-23 2001-01-23 pharmaceutical compositions
GB0101744A GB0101744D0 (en) 2001-01-23 2001-01-23 Pharmaceutical compositions
PCT/GB2001/001027 WO2001066089A2 (en) 2000-03-09 2001-03-09 Pharmaceutical compositions comprising cannabis

Publications (2)

Publication Number Publication Date
PL365005A1 true PL365005A1 (pl) 2004-12-27
PL202673B1 PL202673B1 (pl) 2009-07-31

Family

ID=27255586

Family Applications (1)

Application Number Title Priority Date Filing Date
PL365005A PL202673B1 (pl) 2000-03-09 2001-03-09 Zastosowanie kanabisu, delta 9-tetrahydrokanabinolu do wytwarzania kompozycji farmaceutycznej oraz urządzenie spreju z pompą zawierające kompozycję farmaceutyczną

Country Status (22)

Country Link
US (5) US20030191180A1 (pl)
EP (1) EP1280515B1 (pl)
JP (1) JP5599961B2 (pl)
KR (1) KR20030038536A (pl)
CN (1) CN1258359C (pl)
AT (1) ATE353629T1 (pl)
AU (1) AU782991B2 (pl)
CA (1) CA2402020C (pl)
CY (1) CY1106549T1 (pl)
CZ (1) CZ303537B6 (pl)
DE (2) DE60126599T2 (pl)
DK (1) DK1280515T3 (pl)
ES (1) ES2280343T3 (pl)
HU (1) HU228237B1 (pl)
IL (2) IL151603A0 (pl)
MX (1) MXPA02008778A (pl)
NO (2) NO332663B1 (pl)
NZ (1) NZ544681A (pl)
PL (1) PL202673B1 (pl)
PT (1) PT1280515E (pl)
SI (1) SI1280515T1 (pl)
WO (1) WO2001066089A2 (pl)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050180923A1 (en) * 1997-10-01 2005-08-18 Dugger Harry A.Iii Buccal, polar and non-polar spray containing testosterone
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US20040136915A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US20050163719A1 (en) * 1997-10-01 2005-07-28 Dugger Harry A.Iii Buccal, polar and non-polar spray containing diazepam
US20040141923A1 (en) * 1997-10-01 2004-07-22 Dugger Harry A. Buccal, polar and non-polar spray containing alprazolam
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US20030190286A1 (en) * 1997-10-01 2003-10-09 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
CA2306024C (en) * 1997-10-01 2011-04-26 Flemington Pharmaceutical Corporation Buccal, polar and non-polar spray or capsule
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US20040136914A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20030077228A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
ES2280343T3 (es) 2000-03-09 2007-09-16 Gw Pharma Limited Composiciones farmaceuticas que contienen cannabis.
US6730330B2 (en) 2001-02-14 2004-05-04 Gw Pharma Limited Pharmaceutical formulations
GB0103638D0 (en) * 2001-02-14 2001-03-28 Gw Pharmaceuticals Ltd Pharmaceutical formulations
AU2002231970B2 (en) * 2001-02-14 2007-08-16 CNX Therapeutics Limited Mucoadhesive pharmaceutical formulations
US10004684B2 (en) 2001-02-14 2018-06-26 Gw Pharma Limited Pharmaceutical formulations
GB2384184B (en) * 2002-01-10 2005-01-12 Aea Technology Plc Cannabis aerosol
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
DE10226494A1 (de) * 2002-06-14 2004-01-08 Lts Lohmann Therapie-Systeme Ag Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
PT1542657E (pt) * 2002-08-14 2012-02-29 Gw Pharma Ltd Formulações líquidas canabinóides para administração pela mucosa
AU2005314021B2 (en) * 2004-12-09 2010-02-11 Insys Therapeutics, Inc. Room-temperature stable dronabinol formulations
EP1855666A1 (en) * 2005-02-25 2007-11-21 Unimed Pharmaceuticals, Inc. Dronabinol compositions and methods of using same
CN101198324B (zh) * 2005-06-16 2011-06-08 欧洲凯尔特公司 用于改进剂型的大麻素活性药物成分
MX2007015838A (es) * 2005-06-20 2008-02-22 Unimed Pharmaceutical Inc Dronabinol para el tratamiento de migranas.
US7851419B2 (en) * 2005-09-12 2010-12-14 Nawaz Ahmad Substantially anhydrous sprayable personal lubricant
ES2581212T3 (es) * 2005-11-07 2016-09-02 Murty Pharmaceuticals, Inc. Administración mejorada de tetahidrocannabinol
WO2007123955A2 (en) * 2006-04-19 2007-11-01 Novadel Pharma Inc. Stable hydroalcoholic oral spray formulations and methods
EP2046290A4 (en) * 2006-08-04 2011-08-17 Insys Therapeutics Inc AQUEOUS DRONABINOL FORMULATIONS
CA2673049C (en) * 2006-12-22 2016-02-23 Novadel Pharma Inc. Stable anti-nausea oral spray formulations and methods
WO2008141264A1 (en) * 2007-05-10 2008-11-20 Novadel Pharma Inc. Anti-insomnia compositions and methods
US9035130B2 (en) 2007-05-31 2015-05-19 Gw Pharma Limited Reference plant, a method for its production, extracts obtained therefrom and their use
US8222292B2 (en) 2007-08-06 2012-07-17 Insys Therapeutics, Inc. Liquid cannabinoid formulations
WO2009020666A1 (en) * 2007-08-06 2009-02-12 Insys Therapeutics Inc. Oral cannabinoid liquid formulations and methods of treatment
US8801436B2 (en) * 2008-04-02 2014-08-12 Carson Laboraotories, I, P., Inc. Oral hygiene composition and apparatus and method
AT509000B1 (de) * 2009-10-23 2012-12-15 Rausch Peter Wasserlösliche zubereitungen von cannabinoiden und cannabispräparaten und deren anwendungen
US8445034B1 (en) 2010-11-02 2013-05-21 Albert L Coles, Jr. Systems and methods for producing organic cannabis tincture
US12496271B2 (en) 2019-02-22 2025-12-16 Benuvia Operations, Llc Oral cannabinoid formulations
US11253472B2 (en) 2012-10-04 2022-02-22 Benuvia Therapeutics Llc Oral cannabinoid formulations
US9345771B2 (en) 2012-10-04 2016-05-24 Insys Development Company, Inc. Oral cannabinoid formulations
US10265293B2 (en) 2012-10-04 2019-04-23 Insys Development Company, Inc. Oral cannabinoid formulations
US9532593B2 (en) 2013-12-26 2017-01-03 John Turner Herbal smoking blend
US10821240B2 (en) 2014-02-11 2020-11-03 Vapor Cartridge Technology Llc Methods and drug delivery devices using cannabis
US9220294B2 (en) 2014-02-11 2015-12-29 Timothy McCullough Methods and devices using cannabis vapors
US9380813B2 (en) 2014-02-11 2016-07-05 Timothy McCullough Drug delivery system and method
GB2524469A (en) * 2014-02-14 2015-09-30 Kind Consumer Ltd A cannabinoid inhaler and composition therefor
US9918961B2 (en) 2014-02-19 2018-03-20 Kind Consumer Limited Cannabinoid inhaler and composition therefor
JP6685897B2 (ja) * 2014-03-13 2020-04-22 ステヴァナト グループ インターナショナル エイ．エス． 液体製剤を処理する方法
US10307446B2 (en) 2014-03-21 2019-06-04 St&T International, Inc. Cannabis extraction method and compositions
US20220213299A1 (en) * 2014-03-31 2022-07-07 Boehringer Ingelheim Vetmedica Gmbh Inhaler
WO2015149922A2 (en) * 2014-03-31 2015-10-08 Boehringer Ingelheim Vetmedica Gmbh Inhaler
AU2015280412B2 (en) 2014-06-26 2018-07-26 Island Breeze Systems Ca, Llc MDI related products and methods of use
CA2992923C (en) 2014-07-21 2021-06-29 Pharmaceutical Productions, Inc. Solid dosage form composition for buccal and sublingual administration of cannabinoids
US9565865B2 (en) 2014-08-15 2017-02-14 Imbue LLC Method for making coffee products containing cannabis ingredients
US10897915B2 (en) 2014-08-15 2021-01-26 Blacklist Holdings, Inc. Method for making coffee products containing cannabis ingredients
US11793769B2 (en) 2014-08-25 2023-10-24 Jai Shankar Sukul Device with compositions for delivery to the lungs, the oral mucosa and the brain
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
US9717683B1 (en) 2016-06-29 2017-08-01 Ep Pharma, Llc Low-temperature inhalation administration of cannabinoid entities
AU2017290107A1 (en) 2016-06-29 2019-01-17 CannScience Innovations Inc. Decarboxylated cannabis resins, uses thereof and methods of making same
US9833408B1 (en) * 2016-07-28 2017-12-05 Allen Greenspoon Orally administrable formulation
US10278951B1 (en) * 2016-09-29 2019-05-07 Jon Newland Method of treating opiate dependency using tetrahydrocannabinol extracts
EP3790543A4 (en) 2018-05-11 2022-03-30 Rhodes Technologies Inc. COMPOSITIONS AND DOSAGE FORMS FOR ORAL ADMINISTRATION
US10888596B1 (en) 2018-12-28 2021-01-12 Cold Baked LLC Method of preparing Cannabis extracts
CN112237666B (zh) * 2019-07-17 2022-06-17 东莞市爱的仕机电设备有限公司 一种雾化器及雾化器用的舌下喷嘴
MX2022003189A (es) 2019-09-16 2022-06-08 Vapor Cartridge Tech Llc Sistema de administración de fármacos con sustratos apilables.
US20230233635A1 (en) 2020-05-26 2023-07-27 Rhodes Technologies Cannabinoid compositions and dosage forms for intranasal or inhalational delivery
CN112755301B (zh) * 2021-01-20 2022-03-29 孙洪坤 一种血液病造血干细胞移植用皮肤清洁器
US12029720B2 (en) 2021-04-29 2024-07-09 Tilray Brands, Inc. Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof
EP4122439A1 (de) * 2021-07-23 2023-01-25 Bionorica SE Verwendung von silikonisierten glasbehältern für flüssige pflanzenextrakte
WO2024069423A1 (en) * 2022-09-26 2024-04-04 Feather Company Ltd. Therapeutic formulation

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836667A (en) * 1972-03-24 1974-09-17 Miles Lab Method of producing bronchodilation
BE793865A (fr) * 1972-09-25 1973-07-10 Syntex Corp Composes d'acides xanthone-carboxyliques substitues par des groupes alcenyles et alcynyles
US3836541A (en) * 1972-09-27 1974-09-17 Upjohn Co 3-cyano-2-pyrryl oxamic acids
US3937510A (en) 1973-05-29 1976-02-10 Lew Hyok S Coupled chopsticks
FR2313945A1 (fr) * 1975-06-11 1977-01-07 Fabre Sa Pierre Appareil distributeur de medicaments se presentant sous la forme d'aerosols
GR70283B (pl) 1979-10-02 1982-09-03 Beecham Group Ltd
US4635651A (en) * 1980-08-29 1987-01-13 Jacobs Allen W Process for the inclusion of a solid particulate component into aerosol formulations of inhalable nicotine
DE3688617T2 (de) * 1986-11-03 1993-11-18 Allen W Jacobs Verfahren zur Beimischung einer festen teilchenförmigen Komponente in Aerosolpräparate zur Inhalation des Nikotins.
RU2005472C1 (ru) 1988-02-29 1994-01-15 Омский государственный ветеринарный институт Способ профилактики неспецифической бронхопневмонии молодняка крупного рогатого скота
DE68926717T2 (de) * 1988-04-06 1997-01-23 Mitsubishi Electric Corp Optischer Abstandsdetektor
US5248493A (en) * 1988-08-27 1993-09-28 Fisons Plc Pharmaceutical composition
JPH03153625A (ja) 1989-11-13 1991-07-01 Tsumura & Co 抗アレルギー剤
JP3533228B2 (ja) * 1993-02-23 2004-05-31 トーアエイヨー株式会社 低刺激性ニトログリセリン組成物及びスプレー剤
CN1116104A (zh) 1994-07-31 1996-02-07 禤卫年 百龄康饮品
CN1116101A (zh) 1994-08-01 1996-02-07 程春桂 一种防治咳喘的保健用品及其制备方法
US5536749A (en) * 1994-10-13 1996-07-16 Sl Pharmaceuticals, Inc. Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents
JP2001505171A (ja) * 1996-12-04 2001-04-17 バイオグラン アイルランド（アール アンド ディ）リミテッド 製薬組成物及びその投与のための装置
US5976193A (en) * 1997-04-08 1999-11-02 Cigone Enterprises, Inc. Method composition and system for removing
GB9726916D0 (en) * 1997-12-19 1998-02-18 Danbiosyst Uk Nasal formulation
US6509005B1 (en) * 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler
US6846495B2 (en) * 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
GB2337040B (en) * 1999-06-21 2000-06-07 Bespak Plc Improvements in or relating to dispensing apparatus
CA2341035A1 (en) * 1999-07-08 2001-01-18 Orlando Hung Pulmonary delivery of liposomal-encapsulated cannabinoids
JP2003535813A (ja) * 1999-08-20 2003-12-02 ユニメッド・ファーマシューティカルズ・インコーポレーテッド 半水性溶媒中にデルタ−９−テトラヒドロカンナビノールを含んでなる吸入のための組成物
ES2280343T3 (es) 2000-03-09 2007-09-16 Gw Pharma Limited Composiciones farmaceuticas que contienen cannabis.
PT1542657E (pt) 2002-08-14 2012-02-29 Gw Pharma Ltd Formulações líquidas canabinóides para administração pela mucosa

Also Published As

Publication number Publication date
DE122011100060I1 (de) 2012-02-02
NZ544681A (en) 2008-02-29
HUP0300582A2 (hu) 2003-09-29
CN1441667A (zh) 2003-09-10
AU3760801A (en) 2001-09-17
PL202673B1 (pl) 2009-07-31
HUP0300582A3 (en) 2006-07-28
SI1280515T1 (sl) 2007-06-30
CA2402020C (en) 2006-08-29
ES2280343T3 (es) 2007-09-16
NO332663B1 (no) 2012-11-26
IL151603A0 (en) 2003-04-10
US20120328718A1 (en) 2012-12-27
IL151603A (en) 2007-10-31
NO20024222L (no) 2002-11-06
NO2013011I2 (no) 2015-07-20
JP5599961B2 (ja) 2014-10-01
DK1280515T3 (da) 2007-06-11
KR20030038536A (ko) 2003-05-16
DE60126599D1 (de) 2007-03-29
PT1280515E (pt) 2007-04-30
US8481091B2 (en) 2013-07-09
WO2001066089A2 (en) 2001-09-13
ATE353629T1 (de) 2007-03-15
US8512767B2 (en) 2013-08-20
CZ303537B6 (cs) 2012-11-21
EP1280515B1 (en) 2007-02-14
CA2402020A1 (en) 2001-09-13
HU228237B1 (en) 2013-02-28
WO2001066089A3 (en) 2002-02-21
AU782991B2 (en) 2005-09-15
DE60126599T2 (de) 2007-11-22
NO2013011I1 (no) 2013-06-10
CZ20023017A3 (cs) 2003-04-16
NO20024222D0 (no) 2002-09-04
MXPA02008778A (es) 2005-06-20
US20030191180A1 (en) 2003-10-09
US20100323038A1 (en) 2010-12-23
CY1106549T1 (el) 2012-01-25
US20080071233A1 (en) 2008-03-20
US20130006182A1 (en) 2013-01-03
EP1280515A2 (en) 2003-02-05
JP2003533439A (ja) 2003-11-11
CN1258359C (zh) 2006-06-07

Similar Documents

Publication Publication Date Title
SI1280515T1 (sl) Farmacevtski sestavki, ki vsebujejo kanabis
PL336885A1 (en) Therapeutic products in the aerosol form
AU2003225915A1 (en) Formoterol and mometasone aerosol formulations
MXPA05001567A (es) Formulaciones liquidas de canabinoides para la administracion a traves de la mucosa.
CA2411754A1 (en) 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoic acid and compositions for delivering active agents
ATE128350T1 (de) Pharmazeutische aerosolformulierung.
WO1996040089A3 (en) Aerosol drug formulations containing vegetable oils
US6962691B1 (en) Topical spray compositions
GB0016876D0 (en) Novel formulation
NO20083759L (no) Doserings aerosoler for administrering av farmasoytiske preparater
AU6882796A (en) Pharmaceutical compositions and devices for their administration
HK1041446B (zh) 舌下给药的大麻
WO2003070194A3 (en) Amino acid and peptide-modified forms of glucocorticoids
WO2004103339A3 (en) Improved metered dose inhaler
AU2003215588A1 (en) Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery
DK1161225T3 (da) Doseringsaerosol med isobutan som drivmiddel
MX9604004A (es) Formualciones de farmaco en aerosol que contienen vitamina e.